Serial 88877288
Dead / Abandoned — Abandoned — no statement of use filed (as of 04 Mar 2024)
What this means for you
This application is over — abandoned 04 Mar 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 88877288
- Mark type
- Design / logo
- Filed
- 17 Apr 2020
- Published for opposition
- 08 Dec 2020
- Abandoned
- 04 Mar 2024
- Attorney of record
- Jared M. Barrett
Goods and services
- Class 005 — Pharmaceuticals: therapeutic preparations, namely, antibodies for use in targeting the CCR5 cell receptor, for preventing and/or treating HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, respiratory diseases and disorders; therapeutic preparations for the prevention and/or treatment of HIV, cancer, graft-versus-host disease, autoimmune diseases, nonalcoholic steatohepatitis, respiratory diseases and disorders; therapeutic preparations for the treatment of COVID-19
Owner
- CytoDyn Inc., Vancouver, WA, US
- CytoDyn Inc., Vancouver, WA, US
Prosecution history
- 04 Mar 2024 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 04 Mar 2024 — ABANDONMENT - NO USE STATEMENT FILED
- 11 Aug 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Aug 2023 — SOU EXTENSION 5 GRANTED
- 02 Aug 2023 — SOU EXTENSION 5 FILED
- 10 Aug 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 02 Aug 2023 — SOU TEAS EXTENSION RECEIVED
- 13 Jan 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 11 Jan 2023 — SOU EXTENSION 4 GRANTED
- 11 Jan 2023 — SOU EXTENSION 4 FILED
- 11 Jan 2023 — SOU TEAS EXTENSION RECEIVED
- 28 Jun 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jun 2022 — SOU EXTENSION 3 GRANTED
- 24 Jun 2022 — SOU EXTENSION 3 FILED
- 24 Jun 2022 — SOU TEAS EXTENSION RECEIVED